宫颈癌介入治疗的临床意义

目的研究包括血管栓塞治疗在内的新辅助化疗在宫颈癌治疗中的意义。方法将52例IIa期宫颈癌患者分为观察组和对照组，对宫颈癌IIa期患者术前行包括血管栓塞治疗在内的新辅助化疗，3周后实施手术，对照组患者仅行手术治疗，对比术后两组患者需补充放化疗是否有差异。结果通过术前新辅助化疗，观察组术后需补充放化疗率明显低于对照纽（P〈0．05）。结论宫颈癌患者行包括血管栓塞治疗在内的新辅助化疗，有效地减少了患者术后补充放化疗的几率，提高了患者术后的生存质量。

Objective To study the significance of neoadjuvant chemotherapy including the vascular embolization in the treatment of cervical cancer. Methods 52 cases of cervical cancer patients of IIa stage were divided into experimental group and control group. The patients with cervical cancer of IIa stage were treated by neoadjuvant chemotherapy including the vascular embolization. All patients were operated after three weeks, control group was treated with surgery only and the need of an additional postoperative chemotherapy and radiotherapy was compared between the two groups. Results Through the neoadjuvant chemotherapy before surgery, the rate of chemotherapy and radiotherapy which needed to add postoperatively in the experimental group was significantly lower than that of the control group （ P〈0.05 ） . Conclusions The neoadjuvant chemotherapy including the vascular embolization for the patients with cervical cancer can effectively reduce the probability of chemotherapy and radiotherapy which needs to add postoperatively, and improve the quality of life of those patients.